Official sourcesirishstatutebook.ie · EUR-Lex
Europaius
Ireland
ČeštinaDeutschFrançaisEspañolPolskiItalianoNederlandsÖsterreichBelgiquePortuguêsSvenskaDanskSuomiSlovenčinaMagyarEestiLietuviųLatviešuSlovenščinaHrvatskiΚύπροςMaltiRomânăΕλληνικάLuxembourgБългарски
Ireland

Misuse of Drugs (Amendment) Act 2016

In short

This law amends the Misuse of Drugs Act 1977 to include more substances under drug control and transfers certain licensing functions from the Minister for Health to the Health Products Regulatory Authority.

What it regulates

  • The control of additional dangerous or harmful drugs.
  • The roles of registered nurses and midwives in prescribing, administering, and supplying controlled drugs.
  • The transfer of licensing authority for certain functions from the Minister for Health to the Health Products Regulatory Authority.
  • The revocation of specific older statutory instruments related to misuse of drugs.

Who it concerns

  • Registered medical practitioners, registered dentists, registered veterinary surgeons.
  • Registered nurses and registered midwives.
  • The Minister for Health and the Health Products Regulatory Authority.

Key points

  • The definition of "practitioner" now includes registered nurses and registered midwives.
  • Regulations can be made to allow relevant nurses and midwives to issue prescriptions for controlled drugs, provided the Minister is satisfied it is reasonably safe.
  • Licensing functions previously held by the Minister for Health are transferred to the Health Products Regulatory Authority.
  • Several statutory instruments, including those concerning licence fees, safe custody, exemptions, and methadone supervision, are revoked.
Legal text
Legal text

Misuse of Drugs (Amendment) Act 2016 Skip to content Disclaimer Feedback Helpdesk Gaeilge Léim go dtí an t-ábhar Séanadh Aiseolas Deasc chabhrach English Gaeilge English Produced by the Office of the Attorney General Táirgthe ag Oifig an Ard-Aighne Home Legislation Acts of the Oireachtas Statutory Instruments Pre-1922 Legislation Constitution External Resources Bills (Houses of the Oireachtas) Iris Oifigiúil / Official Gazette Revised Acts (LRC) Classified List of Legislation (LRC) Translations (acts.

  1. ie)Translations (Houses of the Oireachtas) Government Publications for Sale EU Law (EUR-Lex) FAQ Disclaimer Feedback Helpdesk Search Baile Reachtaíocht Achtanna an Oireachtais Ionstraimí Reachtúla Reachtaíocht Réamh-1922 Bunreacht Acmhainní Seachtracha Billí (Tithe an Oireachtais) Iris Oifigiúil Achtanna Athbhreithnithe (CAD) (An Coimisiún um Athchóiriú an Dlí) Liosta Rangaithe Reachtaíochta Aistriúcháin (achtanna.
  2. ie)Aistriúcháin (Tithe an Oireachtais) Foilseacháin Rialtais ar Díol Dlí AE (EUR-Lex) CCanna (Ceisteanna Coitianta) Séanadh Aiseolas Deasc chabhrach Cuardach TitleTeideal Year(
  3. s)or rangeBliain nó blianta nó raon TypeCineál All Legislation Acts Statutory Instruments Advanced SearchCuardach Casta HomeBaile ActsAchtanna 2016 Misuse of Drugs (Amendment) Act 2016 Misuse of Drugs (Amendment) Act 2016 Permanent Page URL View by SectionAmharc de réir Ailt View Full ActAmharc ar an Acht Iomlán Bill History Stair Bille Commencement, Amendments, SIs made under the Act Tosach Feidhme, Leasuithe, IRí arna ndéanamh faoin Acht Open PDFOscail PDF Print Full ActPriontáil an tAcht Iomlán Number 9 of 2016 MISUSE OF DRUGS (AMENDMENT) ACT 2016 CONTENTS Section 1. Definition 2. Amendment of section 1 of Principal Act 3. Amendment of section 5 of Principal Act 4. Amendment of section 13 of Principal Act 5. Amendment of section 21 of Principal Act 6. Amendment of Schedule to Principal Act 7. Revocation of certain statutory instruments 8. Short title, collective citation, construction and commencement SCHEDULE PART 1 Amendment of Paragraph 1A of Schedule to Misuse of Drugs Act 1977 PART 2 Amendment of Paragraph 1B of Schedule to Misuse of Drugs Act 1977 Acts Referred to Misuse of Drugs Act 1977 (No. 12) Misuse of Drugs Acts 1977 to 2015 Nurses and Midwives Act 2011 (No. 41) Number 9 of 2016 MISUSE OF DRUGS (AMENDMENT) ACT 2016 An Act to amend and extend the law relating to the prevention of the misuse of certain dangerous or otherwise harmful drugs and for those purposes to amend the Misuse of Drugs Act 1977 to provide for the control of additional substances; to make further provision for the transfer of functions relating to the grant of licences under that Act from the Minister for Health to the Health Products Regulatory Authority; to revoke certain statutory instruments; and to provide for related matters. [27 th July, 2016] Be it enacted by the Oireachtas as follows: Definition 1. In this Act “Principal Act” means the Misuse of Drugs Act 1977 . Amendment of section 1 of Principal Act 2. Section 1 of the Principal Act is amended, in subsection

(1)— (
  1. a)by the insertion of the following definition: “‘registered midwife’ means a midwife whose name is entered in the midwives division of the register of nurses and midwives under the Nurses and Midwives Act 2011 ;”, (
  2. b)by the substitution of the following for the definition of “registered nurse”: “‘registered nurse’ means a nurse whose name is entered in the nurses division of the register of nurses and midwives under the Nurses and Midwives Act 2011 ;”, and (
  3. c)by the substitution of the following for the definition of “practitioner”: “‘practitioner’ means a registered medical practitioner, a registered dentist, a registered veterinary surgeon, a registered nurse and a registered midwife;”. Amendment of section 5 of Principal Act 3. Section 5 of the Principal Act is amended— (
  4. a)in subsection
(1), by the substitution of the following paragraph for paragraph (f): “(
  1. f)subject to subsection (1A), regulating the issue of prescriptions for controlled drugs and the supply of controlled drugs on prescription by— (
  2. i)registered medical practitioners, registered dentists or registered veterinary surgeons, (
  3. ii)relevant nurses, or (iii) relevant midwives,”, (
  4. b)by the substitution of the following subsection for subsection (1A): “(1A) The Minister shall not make regulations under subsection
(1)(f)(
  1. ii)or (iii) unless the Minister, having had regard to the nature and purpose of the controlled drug (including any deleterious effects which may arise from the misuse thereof), is satisfied that it is reasonably safe to permit the issue of prescriptions for that controlled drug by relevant nurses or relevant midwives.”, (
  2. c)in subsection
(2)(a), by the substitution of “(other than a relevant nurse or a relevant midwife)” for “(other than a registered nurse)”, (d) by the substitution of the following subsection for subsection
(3): “
(3)Subject to section 13, the Minister may make regulations under this section so as to secure that it is not unlawful under this Act for a practitioner who is a relevant nurse or a relevant midwife, for the purpose of the practitioner’s profession as a relevant nurse or a relevant midwife, to prescribe, administer or supply a controlled drug if the Minister, after having had regard to the nature and purpose of the controlled drug (including any deleterious effects which may arise from the misuse thereof), is satisfied that it is reasonably safe to permit the practitioner, for the purpose of the practitioner’s profession as a relevant nurse or a relevant midwife, to prescribe, administer or supply that controlled drug.”, and (e) by the insertion of the following subsection after subsection
(3): “
(4)In this section— ‘relevant midwife’ means a registered midwife or a class of registered midwives; ‘relevant nurse’ means a registered nurse or a class of registered nurses.”. Amendment of section 13 of Principal Act 4. Section 13 of the Principal Act is amended, in subsection
(1)(b), by the substitution of “issued by the Health Products Regulatory Authority” for “issued by the Minister”. Amendment of section 21 of Principal Act 5. Section 21 of the Principal Act is amended, in subsection
(6), by the substitution of “issued under section 14 by the Health Products Regulatory Authority” for “issued by the Minister”. Amendment of Schedule to Principal Act 6. The Schedule to the Principal Act is amended— (
  1. a)in paragraph 1A, by the substitution of the text set out in Part 1 of the Schedule for subparagraph (
  2. a)of that paragraph, and (
  3. b)in paragraph 1B, by the substitution of the text set out in Part 2 of the Schedule for subparagraph (
  4. a)of that paragraph. Revocation of certain statutory instruments 7. The following are revoked: (
  5. a)the Misuse of Drugs (Licence Fees) Regulations 1979 ( S.I. No. 164 of 1979 ); (
  6. b)the Misuse of Drugs (Safe Custody) Regulations 1982 ( S.I. No. 321 of 1982 ); (
  7. c)the Misuse of Drugs (Exemption) Order 1988 ( S.I. No. 326 of 1988 ); (
  8. d)the Misuse of Drugs Regulations 1988 ( S.I. No. 328 of 1988 ); (
  9. e)the Misuse of Drugs (Designation) Order 1998 ( S.I. No. 69 of 1998 ); (
  10. f)the Misuse of Drugs (Supervision of Prescription and Supply of Methadone) Regulations 1998 ( S.I. No. 225 of 1998 ). Short title, collective citation, construction and commencement 8.
(1)This Act may be cited as the Misuse of Drugs (Amendment) Act 2016.
(2)The Misuse of Drugs Acts 1977 to 2015 and this Act may be cited together as the Misuse of Drugs Acts 1977 to 2016 and shall be construed together as one Act.
(3)This Act shall come into operation on such day or days as the Minister for Health may by order or orders appoint either generally or with reference to any particular purpose or provision and different days may be so appointed for different purposes or provisions. SCHEDULE Section 6 Part 1 Amendment of Paragraph 1A of Schedule to Misuse of Drugs Act 1977 “(
  1. a)N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide Alfentanil (3-Amino-2,2-dimethylpropyl)-4-aminobenzoate 5-(2-Aminopropyl) indole 1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-pentanone N-(1-Benzyl-4-piperidyl) propionanilide 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine 1-(4-Bromofuro[2,3-f][1]benzofuran-8-yl)propan-2-amine Carfentanil Cathinone 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine 1-Cyclohexyl-4-(1,2-diphenylethyl) piperazine 3,4-Dichloro-N-[[1-(dimethylamino) cyclohexyl]methyl]benzamide Dihydroetorphine [2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl) pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone Dimethocaine 3-Dimethylheptyl-11-hydroxyhexahydrocannabinol Eticyclidine Etryptamine 1-(2-Fluorophenyl)-2-methylaminopropan-1-one 1-(3-Fluorophenyl)-2-methylaminopropan-1-one 1-(4-Fluorophenyl)-2-methylaminopropan-1-one 9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol [9-Hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate N-Hydroxy-tenamphetamine 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine Khat (being the leaves of Catha edulis (Celastraceae)) Lisdexamphetamine Lofentanil Methcathinone 2-(3-Methoxyphenyl)-2-(ethylamino) cyclohexanone 1-(4-Methoxyphenyl)-2-(methylamino) propan-1-one Methyl (2S,4aR,6aR,7R,10aS,10bR)-9-acetyloxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo[f]isochromene-7-carboxylate and any product, whether natural or otherwise, including any plant or plant material of any kind or description, which contains any proportion of the said substance 2-Methylamino-1-(3,4-methylenedioxyphenyl) butan-1-one 2-Methylamino-1-(3,4-methylenedioxyphenyl) propan-1-one 4-Methyl-aminorex (8-Methyl-8-azabicyclo[3.2.1]octan-3-yl)-4-fluorobenzoate Methyl 2-[[1-(cyclohexylmethyl) indole-3-carbonyl]amino]-3,3-dimethylbutanoate Methyl (E)-2-[(2S,3S,7aS,12bS)-3-ethyl-7a-hydroxy-8-methoxy-2,3,4,6,7,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate and any product, whether natural or otherwise, including any plant or plant material of any kind or description, which contains any proportion of the said substance Methyl (E)-2-[(2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b- octahydroindolo[2,3- a]quinolizin-2-yl]-3-methoxyprop-2-enoate and any product, whether natural or otherwise, including any plant or plant material of any kind or description, which contains any proportion of the said substance 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine α-Methyl-4-(methylthio) phenethylamine 1-(4-Methylphenyl)-2-methylaminopropan-1-one Nabilone Oripavine Phencyclidine 1-Phenylcyclohexylamine 4-(1-Phenylcyclohexyl) morpholine 1-Piperidinocyclohexanecarbonitrile Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate Remifentanil Rolicyclidine Sufentanil Tapentadol Tenocyclidine N-[1-(2-Thenyl)-4-piperidyl]propionanilide 4-[1-(2-Thienyl) cyclohexyl]morpholine 1-[1-(2-Thienyl) cyclohexyl]pyrrolidine Tilidine.”. Part 2 Amendment of Paragraph 1B of Schedule to Misuse of Drugs Act 1977 “(
  2. a)Alprazolam Amineptine Aminorex Amphetaminil 2-Benzhydrylpiperidine Bromazepam Brotizolam Buprenorphine Butan-1,4-diol Butorphanol Camazepam Cathine Chlordiazepoxide Clobazam Clonazepam Clorazepic acid Clotiazepam Cloxazolam Delorazepam Dextropropoxyphene Diazepam Diethylpropion Dihydrofuran-2(3H)-one Estazolam Ethchlorvnol Ethinamate N-Ethylamphetamine Ethyl loflazepate Fencamfamin Fenethylline Fenproporex Fludiazepam Flunitrazepam Flurazepam Glutethimide Halazepam Haloxazolam 4-Hydroxybutanoic acid Ketamine Ketazolam Lefetamine Loprazolam Lorazepam Lormetazepam Mazindol Mecloqualone Medazepam Mefenorex Meprobamate Mesocarb Methyprylone Midazolam Nalbuphine Nimetazepam Nitrazepam Nordazepam Oxazepam Oxazolam Pemoline Pentazocine Phenazepam Phentermine Pinazepam Prazepam Propylhexedrine Pyrovalerone Selegiline Temazepam Tetrazepam Triazolam Zaleplon Zipeprol Zolpidem Zopiclone.”. Privacy Statement Accessibility European Legislation Identifier (PDF) Open Data License Ráiteas Príobháideachais Inrochtaineacht Aitheantóir Eorpach Reachtaíochta (ELI) Ceadúnas Sonraí Oscailte Liosta Fianán © Government of Ireland. Oireachtas Copyright Material is reproduced with the permission of the Houses of the Oireachtas © Rialtas na hÉireann. Atáirgtear ábhar faoi Chóipcheart le cead ó Thithe an Oireachtais

AI explanation based on the official legal text. Indicative, not a substitute for legal advice.